Dr. Alissa Won, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1460 Ritchie Hwy Ste 209, Arnold, MD 21012 Phone: 410-789-7337 Fax: 410-789-0425 |
Dr. Candace Ann Tesch, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1460 Ritchie Hwy, Arnold, MD 21012 Phone: 410-789-7337 Fax: 410-789-0425 |
Jacqueline Kelly, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 269 Peninsula Farm Rd, Suite F, Arnold, MD 21012 Phone: 410-518-9808 Fax: 410-518-9842 |
Dr. Rebecca F Vickers, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1460 Ritchie Hwy Ste 209, Arnold, MD 21012 Phone: 410-789-7337 Fax: 410-789-0425 |
Dr. Yann Yann Lin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1212 Asquithpines Pl, Arnold, MD 21012 Phone: 410-647-4997 Fax: 410-647-8115 |
Dr. Shannon L West, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1509 Ritchie Hwy, Arnold, MD 21012 Phone: 410-757-7600 Fax: 410-626-8043 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its Board of Directors has authorized the repurchase of up to $2 million of its outstanding common stock. This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
In a study that included more than 800 women who had undergone surgery for breast cancer, the majority reported some level of pain 12 months after surgery, and factors associated with pain included chronic preoperative pain, chemotherapy, preoperative depression and pain in the area to be operated, according to a study appearing in the January 1 issue of JAMA.
Scientists at two Northern Arizona University research centers-the Pathogen and Microbiome Institute and the Center for Health Equity Research-recently received grants totaling $175,000 from the Flinn Foundation in support of projects directed at responding to the COVID-19 threat.
A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
› Verified 8 days ago